Share on Pinterest Researchers have compared the effectiveness of weight loss medications such as tirzepatide and semaglutide. Jaap Arriens/NurPhoto via Getty Images Tirzepatide and semaglutide are ...
Researchers from Truveta, a health data analytics company, analyzed electronic health records for more than 18,000 adults, all of whom had overweight or obesity, who were using these medications in ...
Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive lifestyle ...
A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...
Please provide your email address to receive an email when new articles are posted on . A dose of 15 mg tirzepatide produced a mean weight loss of 15% in patients after a year of treatment. Some of ...
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide ...
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that around two thirds of participants of the SURMOUNT-1 trial had only regained 5% ...
Hosted on MSN
Study: Tirzepatide improves blood sugar control in children with poorly controlled type 2 diabetes
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes ...
Results from a recent study suggest that tirzepatide may be more effective in helping people who have obesity or overweight lose weight than semaglutide. People interested in using medications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback